INTRODUCTION
TGFfl is a pleiotrophic cytokine produced by a number of different cell types including platelets, macrophages, fibroblasts, and T and B lymphocytes. TGFfl is secreted in a 100-kD biologically inactive latent form. This latency peptide can be cleaved by a change in pH or proteolysis to yield a 25-kD disulfide-bonded homodimer (reviewed in Roberts and Sporn, 1990) . Five types of TGF/J have been cloned: TGFfll, 2, and 3 were originally described in humans (Assoian et al., 1983; Wrann et al., 1987; ten Dikje et al., 1988) ; TGF/J4 has been found only in chickens (Jakowlew et al., 1988) ; TGF//5 has been found only in Xenopus (Roberts and Sporn, 1990 of identity include a highly conserved site and nine conserved cleavage cysteine residues. TGFfl 1 through 5 also show functional conservation in a number of assays, including the inhibition of proliferation of mink lung fibroblasts (MLF) and the stimulation of normal rat kidney (NRK) fibroblast colony formation in the presence of epidermal growth factor (Roberts and Sporn, 1990 (Massague, 1990) . Kehrl et al. (1986)  Haynes and Cohen, 1993 TGCF SN. Figure 6 shows that the anti-TGFfl2 has no effect, whereas the anti-TGFfl5 reverses the inhibitory activity found in the acid-treated supernatant.
DISCUSSION
In mammals, TGFfl is produced by mitogen-activated T cells, inhibits IL-2-dependent T-cell proliferation, and downregulates the immune response (Kehrl et al., 1986 Pasquier, 1990) . Xenopus leukocytes produce an IL-l-like cytokine . Xenopus T cells produce additional cytokines involved in T-and B-cell proliferation (Cohen and Haynes, 1991) and also exhibit MHC-restricted cytotoxicity (Harding, 1990 Production of SAS TCGF SN SAS TCGF SN was generated as previously described 
